Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 26 - 29 October 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.
This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.
Chairman, CEO, Kiromic
European Sales Specialist, Lunaphore
Bioink Production Engineer, CELLINK
Director Field Application Scientist, Ultivue
Director of Biopharma Business Development, Predicine
Principal Statistician, Consulting Services, IDDI
Senior Research Scientist, Ludwig Institute for Cancer Research
Technical Specialist, Sino Biological
CSO & Co-Founder, Evorion Biotechnologies
Oncologist, University of Iowa
Senior Scientist, NeoGenomics
Research and Development Director, Transcure Bioservices